Motohiro Hirao

Osaka National Hospital — Japan

Medicine · Health Sciences

35h-index5.0kcitations438works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(164), Metastasis and carcinoma case studies(74), Esophageal Cancer Research and Treatment(65), Gastrointestinal Tumor Research and Treatment(63), Phytochemical Studies and Bioactivities(57)

Publications436 total

A Case of Sigmoid Colon Cancer with Intussusception and Rectal Prolapse Treated by Laparoscopic Surgery and Transanal Surgery
The Japanese Journal of Gastroenterological Surgery·2025Open Access
Embolization by Gelatin Sponge for Tract Closure After Inappropriate Procedure of Percutaneous Endoscopic Gastrostomy: Safe Management of Hepatic Injury After Transhepatic Placement
DEN Open·2025Open Access
Supplementary Table S4 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S4 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S3 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S1 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S3 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S2 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S2 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S5 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S1 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Influence of Hospital and Surgeon Volumes on Clinical Outcomes After Standard Surgery for Advanced Gastric Cancer: Supplementary Analysis of the Multicenter Randomized Phase <scp>III</scp> Trial <scp>JCOG1001</scp>
Annals of Gastroenterological Surgery·2025Open Access
Rupture of Life‐Threatening Hepatic Artery Pseudoaneurysm After Endoscopic Ultrasonography‐guided Hepaticogastrostomy: Successful Management With Emergency Transcatheter Arterial Embolization
DEN Open·2025Open Access
Postoperative Prognostic Nutritional Index as a Useful Prognostic Factor in Patients With Gastric Cancer
Annals of Gastroenterological Surgery·2025Open Access
Benefits of neoadjuvant chemotherapy: is the prognosis of ypN0 patients after neoadjuvant chemotherapy comparable to that of pN0 patients undergoing surgery alone?
Esophagus·2025Open Access
Long‐Term Survival of Two Versus Three Courses of Preoperative Cisplatin and Fluorouracil Plus Docetaxel for Locally Advanced Esophageal Cancer: A Multicenter Randomized Phase <scp>II</scp> Trial
Annals of Gastroenterological Surgery·2025Open Access
Su1187: ALCOHOL CONSUMPTION, SMOKING AND THEIR CESSATION FOR FIELD CARCINOGENESIS IN THE ESOPHAGUS, HEAD, AND NECK: 10-YEAR FOLLOW-UP RESULTS FROM A MULTICENTER COHORT STUDY
Gastroenterology·2025
Exploring predictive biomarkers of efficacy and survival with nivolumab treatment for unresectable/recurrent esophageal squamous cell carcinoma
Esophagus·2025Open Access
A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final Results
Anticancer Research·2025
Bile reflux is a risk factor for metachronous recurrence in patients with early gastric cancer
Endoscopy·2025
page 1 of 22Next →

Frequent Co-authors

Kazumasa Fujitani(24), Toshimasa Tsujinaka(20), Yuichiro� Doki(17), Yutaka Kimura(16), Yukinori Kurokawa(14), Kazuyoshi Yamamoto(11), Masahiko Yano(10), Shuji Takiguchi(9), Makoto Yamasaki(9), Masaki Mori(9), Shoji Nakamori(8), Hiroshi Imamura(8), Mitsugu Sekimoto(7), Hiroshi Miyata(7), Tomoki Makino(7), Junya Fujita(7), Atsushi Miyamoto(6), Masanori Terashima(6), Hitoshi Katai(6), Mitsuru Sasako(6)